Allspring Global Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.4M | Sell |
130,505
-5,442
| -4% | -$1.35M | 0.05% | 393 |
|
2025
Q1 | $32.6M | Sell |
135,947
-7,790
| -5% | -$1.87M | 0.06% | 388 |
|
2024
Q4 | $46.9M | Sell |
143,737
-4,985
| -3% | -$1.63M | 0.08% | 312 |
|
2024
Q3 | $49.8M | Sell |
148,722
-7,691
| -5% | -$2.57M | 0.08% | 316 |
|
2024
Q2 | $42.7M | Sell |
156,413
-7,370
| -4% | -$2.01M | 0.07% | 343 |
|
2024
Q1 | $56.6M | Sell |
163,783
-2,344
| -1% | -$811K | 0.09% | 285 |
|
2023
Q4 | $53.6M | Buy |
166,127
+17,341
| +12% | +$5.6M | 0.09% | 299 |
|
2023
Q3 | $53.3M | Sell |
148,786
-86,117
| -37% | -$30.9M | 0.09% | 275 |
|
2023
Q2 | $89.1M | Sell |
234,903
-24,299
| -9% | -$9.21M | 0.14% | 172 |
|
2023
Q1 | $124M | Sell |
259,202
-12,785
| -5% | -$6.12M | 0.21% | 113 |
|
2022
Q4 | $114M | Buy |
271,987
+5,282
| +2% | +$2.22M | 0.2% | 127 |
|
2022
Q3 | $111M | Buy |
266,705
+34,780
| +15% | +$14.5M | 0.2% | 124 |
|
2022
Q2 | $115M | Sell |
231,925
-51,665
| -18% | -$25.6M | 0.19% | 130 |
|
2022
Q1 | $160M | Buy |
283,590
+26,539
| +10% | +$14.9M | 0.2% | 123 |
|
2021
Q4 | $194M | Buy |
+257,051
| New | +$194M | 0.22% | 115 |
|